The DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
Amikacin: Uses, Resistance, and Prospects for Inhibition
Open accessAbstract
Aminoglycosides are a group of antibiotics used since the 1940s to primarily treat a broad spectrum of bacterial infections. The primary resistance mechanism against these antibiotics is enzymatic modification by aminoglycoside-modifying enzymes that are divided into acetyl-transferases, phosphotransferases, and nucleotidyltransferases. To overcome this problem, new semisynthetic aminoglycosides were developed in the 70s. The most widely used semisynthetic aminoglycoside is amikacin, which is refractory to most aminoglycoside modifying enzymes. Amikacin was synthesized by acylation with the l-(−)-γ-amino-α-hydroxybutyryl side chain at the C-1 amino group of the deoxystreptamine moiety of kanamycin A. The main amikacin resistance mechanism found in the clinics is acetylation by the aminoglycoside 6′-N-acetyltransferase type Ib [AAC(6′)-Ib], an enzyme coded for by a gene found in integrons, transposons, plasmids, and chromosomes of Gram-negative bacteria. Numerous efforts are focused on finding strategies to neutralize the action of AAC(6′)-Ib and extend the useful life of amikacin. Small molecules as well as complexes ionophore-Zn+2 or Cu+2 were found to inhibit the acetylation reaction and induced phenotypic conversion to susceptibility in bacteria harboring the aac(6′)-Ib gene. A new semisynthetic aminoglycoside, plazomicin, is in advance stage of development and will contribute to renewed interest in this kind of antibiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trott, O., & Olson, A. J. (2010) · Journal of Computational Chemistry · doi:10.1002/jcc.21334 · Cited by 38,412
Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., Repasky, M. P., Knoll, E. H., Shelley, M., Perry, J. K., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0306430 · Cited by 10,057
Halgren, T. A., Murphy, R. B., Friesner, R. A., Beard, H. S., Frye, L. L., Pollard, W. T., & Banks, J. L. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030644s · Cited by 5,177
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Aminoglycoside modifying enzymes
Ramirez, M. S., & Tolmasky, M. E. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.08.003 · Cited by 1,464
Self-citationShaw, K. J., Rather, P. N., Hare, R. S., & Miller, G. H. (1993) · Microbiological Reviews · doi:10.1128/mmbr.57.1.138-163.1993 · Cited by 1,196
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase
Robicsek, A., Strahilevitz, J., Jacoby, G. A., Macielag, M., Abbanat, D., Hye Park, C., Bush, K., & Hooper, D. C. (2006) · Nature Medicine · doi:10.1038/nm1347 · Cited by 1,013
Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
Tamma, P. D., Cosgrove, S. E., & Maragakis, L. L. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05041-11 · Cited by 836
Aminoglycosides: Nephrotoxicity
Mingeot-Leclercq, M.-P., & Tulkens, P. M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1003 · Cited by 757
Molecular Insights into Aminoglycoside Action and Resistance
Magnet, S., & Blanchard, J. S. (2005) · Chemical Reviews · doi:10.1021/cr0301088 · Cited by 669
Versatility of Aminoglycosides and Prospects for Their Future
Vakulenko, S. B., & Mobashery, S. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.3.430-450.2003 · Cited by 643
Experience with a once-daily aminoglycoside program administered to 2,184 adult patients
Nicolau, D. P., Freeman, C. D., Belliveau, P. P., Nightingale, C. H., Ross, J. W., & Quintiliani, R. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.3.650 · Cited by 641
Uniform nomenclature for bacterial plasmids: a proposal
Novick, R. P., Clowes, R. C., Cohen, S. N., Curtiss, R., Datta, N., & Falkow, S. (1976) · Bacteriological Reviews · doi:10.1128/br.40.1.168-189.1976 · Cited by 630
Mechanism of bactericidal action of aminoglycosides
Davis, B. D. (1987) · Microbiological Reviews · doi:10.1128/mmbr.51.3.341-350.1987 · Cited by 620
Bacterial uptake of aminoglycoside antibiotics
Taber, H. W., Mueller, J. P., Miller, P. F., & Arrow, A. S. (1987) · Microbiological Reviews · doi:10.1128/mmbr.51.4.439-457.1987 · Cited by 598
Mechanisms of resistance to aminoglycoside antibiotics: overview and perspectives
Garneau-Tsodikova, S., & Labby, K. J. (2016) · MedChemComm · doi:10.1039/c5md00344j · Cited by 576
Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis
Caminero, J. A., Sotgiu, G., Zumla, A., & Migliori, G. B. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70139-0 · Cited by 574
Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding
Chen, L., Mathema, B., Chavda, K. D., DeLeo, F. R., Bonomo, R. A., & Kreiswirth, B. N. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2014.09.003 · Cited by 554
Goh, E.-B., Yim, G., Tsui, W., McClure, J., Surette, M. G., & Davies, J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252607699 · Cited by 547
Biological metals and metal-targeting compounds in major neurodegenerative diseases
Barnham, K. J., & Bush, A. I. (2014) · Chem. Soc. Rev. · doi:10.1039/c4cs00138a · Cited by 497
Bacterial Antisense RNAs: How Many Are There, and What Are They Doing?
Thomason, M. K., & Storz, G. (2010) · Annual Review of Genetics · doi:10.1146/annurev-genet-102209-163523 · Cited by 352
Rumbo, C., Fernández-Moreira, E., Merino, M., Poza, M., Mendez, J. A., Soares, N. C., Mosquera, A., Chaves, F., & Bou, G. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00929-10 · Cited by 351
Mechanisms of antibiotic resistance
Lin, J., Nishino, K., Roberts, M. C., Tolmasky, M., Aminov, R. I., & Zhang, L. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00034 · Cited by 343
Self-citationVesicle-Mediated Transfer of Virulence Genes from Escherichia coli O157:H7 to Other Enteric Bacteria
Yaron, S., Kolling, G. L., Simon, L., & Matthews, K. R. (2000) · Applied and Environmental Microbiology · doi:10.1128/aem.66.10.4414-4420.2000 · Cited by 338
Molecular understanding of aminoglycoside action and resistance
Jana, S., & Deb, J. K. (2006) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-005-0279-0 · Cited by 336
DeLeo, F. R., Chen, L., Porcella, S. F., Martens, C. A., Kobayashi, S. D., Porter, A. R., Chavda, K. D., Jacobs, M. R., Mathema, B., Olsen, R. J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321364111 · Cited by 329
Modulation of RNA function by aminoglycoside antibiotics
Schroeder, R. (2000) · The EMBO Journal · doi:10.1093/emboj/19.1.1 · Cited by 325
Ferretti, J. J., Gilmore, K. S., & Courvalin, P. (1986) · Journal of Bacteriology · doi:10.1128/jb.167.2.631-638.1986 · Cited by 301
He, S., Hickman, A. B., Varani, A. M., Siguier, P., Chandler, M., Dekker, J. P., & Dyda, F. (2015) · mBio · doi:10.1128/mbio.00762-15 · Cited by 301
Inhibition of tobramycin diffusion by binding to alginate
Nichols, W. W., Dorrington, S. M., Slack, M. P., & Walmsley, H. L. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.4.518 · Cited by 298
Woodford, N., Carattoli, A., Karisik, E., Underwood, A., Ellington, M. J., & Livermore, D. M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00688-09 · Cited by 283
Drug‐induced ototoxicity: Mechanisms, Pharmacogenetics, and protective strategies
Lanvers‐Kaminsky, C., Zehnhoff‐Dinnesen, A. A., Parfitt, R., & Ciarimboli, G. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.603 · Cited by 277
Aminoglycoside induced ototoxicity
Guthrie, O. W. (2008) · Toxicology · doi:10.1016/j.tox.2008.04.015 · Cited by 261
Wright, H., Bonomo, R. A., & Paterson, D. L. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.09.001 · Cited by 256
Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital
Gerding, D. N., Larson, T. A., Hughes, R. A., Weiler, M., Shanholtzer, C., & Peterson, L. R. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.7.1284 · Cited by 246
Clioquinol: Review of its Mechanisms of Action and Clinical Uses in Neurodegenerative Disorders
Bareggi, S. R., & Cornelli, U. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00231.x · Cited by 243
Synthesis and Spectrum of the Neoglycoside ACHN-490
Aggen, J. B., Armstrong, E. S., Goldblum, A. A., Dozzo, P., Linsell, M. S., Gliedt, M. J., Hildebrandt, D. J., Feeney, L. A., Kubo, A., Matias, R. D., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00572-10 · Cited by 243
Prammananan, T., Sander, P., Brown, B. A., Frischkorn, K., Onyi, G. O., Zhang, Y., Böttger, E. C., & Wallace, Jr. (1998) · The Journal of Infectious Diseases · doi:10.1086/515328 · Cited by 241
Miller, G. H., Sabatelli, F. J., Hare, R. S., Glupczynski, Y., Mackey, P., Shlaes, D., Shimizu, K., Shaw, K. J., & Groups, A. R. S. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s46 · Cited by 235
Ramirez, M. S., Traglia, G. M., Lin, D. L., Tran, T., & Tolmasky, M. E. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.plas-0016-2013 · Cited by 212
Self-citationInhaled Antibiotics for Lower Airway Infections
Quon, B. S., Goss, C. H., & Ramsey, B. W. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201311-395fr · Cited by 207
Bacterial GCN5-Related N-Acetyltransferases: From Resistance to Regulation
Favrot, L., Blanchard, J. S., & Vergnolle, O. (2016) · Biochemistry · doi:10.1021/acs.biochem.5b01269 · Cited by 197
Rouch, D. A., Byrne, M. E., Kong, Y. C., & Skurray, R. A. (1987) · Microbiology · doi:10.1099/00221287-133-11-3039 · Cited by 192
The Future of Aminoglycosides: The End or Renaissance?
Houghton, J. L., Green, K. D., Chen, W., & Garneau‐Tsodikova, S. (2010) · ChemBioChem · doi:10.1002/cbic.200900779 · Cited by 189
Characterization of the chromosomal aac(6')-Ii gene specific for Enterococcus faecium
Costa, Y., Galimand, M., Leclercq, R., Duval, J., & Courvalin, P. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.9.1896 · Cited by 185
The Integron: Adaptation On Demand
Escudero*, J. A., Loot*, C., Nivina, A., & Mazel, D. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mdna3-0019-2014 · Cited by 185
Structure and Functional Diversity of GCN5-Related N-Acetyltransferases (GNAT)
Salah Ud-Din, A., Tikhomirova, A., & Roujeinikova, A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071018 · Cited by 180
Rise and dissemination of aminoglycoside resistance: the aac(6′)-Ib paradigm
Ramirez, M. S., Nikolaidis, N., & Tolmasky, M. E. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00121 · Cited by 179
Self-citationInhaled Amikacin for Treatment of Refractory Pulmonary Nontuberculous Mycobacterial Disease
Olivier, K. N., Shaw, P. A., Glaser, T. S., Bhattacharyya, D., Fleshner, M., Brewer, C. C., Zalewski, C. K., Folio, L. R., Siegelman, J. R., Shallom, S., et al. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201307-231oc · Cited by 176
Intratympanic gentamicin for Ménière's disease or syndrome
Pullens, B., & van Benthem, P. P. G. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008234.pub2 · Cited by 175
Class 1 integrons as invasive species
Gillings, M. R. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.03.002 · Cited by 173
Antimicrobial Agents: Antibacterials and Antifungals
(2005) · ASM Press eBooks · doi:10.1128/9781555815929 · Cited by 173
Liposome-encapsulated aminoglycosides in pre-clinical and clinical studies
Schiffelers, R. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.3.333 · Cited by 163
Side effects of aminoglycosides on the kidney, ear and balance in cystic fibrosis
Prayle, A., Watson, A., Fortnum, H., & Smyth, A. (2010) · Thorax · doi:10.1136/thx.2009.131532 · Cited by 162
Aminoglycoside-induced nephrotoxicity in children
McWilliam, S. J., Antoine, D. J., Smyth, R. L., & Pirmohamed, M. (2017) · Pediatric Nephrology · doi:10.1007/s00467-016-3533-z · Cited by 159
Acinetobacter baumannii transfers the blaNDM-1 gene via outer membrane vesicles
Chatterjee, S., Mondal, A., Mitra, S., & Basu, S. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx131 · Cited by 156
Antibiotics that target protein synthesis
McCoy, L. S., Xie, Y., & Tor, Y. (2010) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.60 · Cited by 152
Marchaim, D., Kaye, K. S., Ouellette, M., Sobel, J. D., & Mayers, D. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-46718-4 · Cited by 141
Labby, K. J., & Garneau‐Tsodikova, S. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.80 · Cited by 140
Ruiz, E., Sáenz, Y., Zarazaga, M., Rocha‐Gracia, R. D. C., Martínez-Martínez, L., Arlet, G., & Torres, C. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr548 · Cited by 135
Gentamicin-induced ototoxicity in hemodialysis patients is ameliorated by N-acetylcysteine
Feldman, L., Efrati, S., Eviatar, E., Abramsohn, R., Yarovoy, I., Gersch, E., Averbukh, Z., & Weissgarten, J. (2007) · Kidney International · doi:10.1038/sj.ki.5002295 · Cited by 124
Inhibition of RNase P RNA cleavage by aminoglycosides
Mikkelsen, N. E., Brännvall, M., Virtanen, A., & Kirsebom, L. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6155 · Cited by 120
Antisense antimicrobial therapeutics
Sully, E. K., & Geller, B. L. (2016) · Current Opinion in Microbiology · doi:10.1016/j.mib.2016.05.017 · Cited by 120
Walkty, A. J., Adam, H. J., Baxter, M. R., Denisuik, A. J., Lagacé-Wiens, P. R. S., Karlowsky, J. A., Hoban, D. J., & Zhanel, G. G. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02744-13 · Cited by 116
Hodel-Christian, S. L., & Murray, B. E. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.6.1147 · Cited by 113
Suppression of premature termination codons as a therapeutic approach
Keeling, K. M., Wang, D., Conard, S. E., & Bedwell, D. M. (2012) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2012.694846 · Cited by 111
Reyes‐Lamothe, R., Tran, T., Meas, D., Lee, L. N., Li, A. M., Sherratt, D. J., & Tolmasky, M. E. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt918 · Cited by 108
Self-citationCombating evolution with intelligent design: the neoglycoside ACHN-490
Armstrong, E. S., & Miller, G. H. (2010) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.09.004 · Cited by 107
Vestibular and Cochlear Toxicity of Aminoglycosides - A review
正明, 寺. (2000) · Acta Oto-Laryngologica · doi:10.1080/00016480050218627 · Cited by 104
Saberi, F., Kamali, M., Najafi, A., Yazdanparast, A., & Moghaddam, M. M. (2016) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-016-0007-z · Cited by 98
Amikacin, an Aminoglycoside with Marked Activity against Antibiotic-Resistant Clinical Isolates
PRICE, K. E., DeFuria, M. D., & Pursiano, T. A. (1976) · The Journal of Infectious Diseases · doi:10.1093/infdis/135.supplement_2.s249 · Cited by 97
Hitting bacteria at the heart of the central dogma: sequence-specific inhibition
Rasmussen, L. C. V., Petersen, H. U., & Mortensen, K. K. (2007) · Microbial Cell Factories · doi:10.1186/1475-2859-6-24 · Cited by 97
Galani, I., Souli, M., Daikos, G. L., Chryssouli, Z., Poulakou, G., Psichogiou, M., Panagea, T., Argyropoulou, A., Stefanou, I., Plakias, G., et al. (2012) · Journal of Chemotherapy · doi:10.1179/1973947812y.0000000015 · Cited by 96
Chen, L., Chavda, K. D., Laham, N. A., Melano, R. G., Jacobs, M. R., Bonomo, R. A., & Kreiswirth, B. N. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01397-13 · Cited by 89
Aminoglycoside suppression of nonsense mutations in severe hemophilia
James, P. D., Raut, S., Rivard, G., Poon, M., Warner, M., McKenna, S., Leggo, J., & Lillicrap, D. (2005) · Blood · doi:10.1182/blood-2005-03-1307 · Cited by 85
Complete Nucleotide Sequence of Klebsiella pneumoniae Multiresistance Plasmid pJHCMW1
Sarno, R., McGillivary, G., Sherratt, D. J., Actis, L. A., & Tolmasky, M. E. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3422-3427.2002 · Cited by 81
Self-citationTulkens, P. M. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/27.suppl_c.49 · Cited by 81
Burk, D. L., Ghuman, N., Wybenga-Groot, L. E., & Berghuis, A. M. (2003) · Protein Science · doi:10.1110/ps.0233503 · Cited by 81
Amikacin in Critically Ill Patients: A Review of Population Pharmacokinetic Studies
Marsot, A., Guilhaumou, R., Riff, C., & Blin, O. (2016) · Clinical Pharmacokinetics · doi:10.1007/s40262-016-0428-x · Cited by 81
Park, S. R., Park, J. W., Ban, Y. H., Sohng, J. K., & Yoon, Y. J. (2012) · Natural Product Reports · doi:10.1039/c2np20092a · Cited by 76
Jenkins, A., Thomson, A. H., Brown, N. M., Semple, Y., Sluman, C., MacGowan, A. P., Lovering, A. M., & Wiffen, P. J. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw250 · Cited by 76
Düzgüneş, N., Perumal, V. K., Kesavalu, L. N., Goldstein, J. A., Debs, R. J., & Gangadharam, P. R. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.9.1404 · Cited by 74
Aminoglycosides: how should we use them in the 21st century?
Jackson, J., Chen, C., & Buising, K. L. (2013) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000012 · Cited by 74
Russell, R. J. M., Murray, J. B., Lentzen, G., Haddad, J., & Mobashery, S. (2003) · Journal of the American Chemical Society · doi:10.1021/ja029736h · Cited by 72
Plasmid Replication Control by Antisense RNAs
Brantl, S. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.plas-0001-2013 · Cited by 70
Amphiphilic Tobramycin Analogues as Antibacterial and Antifungal Agents
Shrestha, S. K., Fosso, M. Y., Green, K. D., & Garneau‐Tsodikova, S. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00229-15 · Cited by 69
Warburg, G., Hidalgo‐Grass, C., Partridge, S. R., Tolmasky, M. E., Temper, V., Moses, A. E., Block, C., & Strahilevitz, J. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr552 · Cited by 66
Self-citationRice, L. B., Carias, L. L., Hutton, R. A., Rudin, S. D., Endimiani, A., & Bonomo, R. A. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00493-08 · Cited by 66
Yagi, K., Ishii, M., Namkoong, H., Asami, T., Iketani, O., Asakura, T., Suzuki, S., Sugiura, H., Yamada, Y., Nishimura, T., et al. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2665-5 · Cited by 62
Mechanisms of Evolution in High-Consequence Drug Resistance Plasmids
He, S., Chandler, M., Varani, A. M., Hickman, A. B., Dekker, J. P., & Dyda, F. (2016) · mBio · doi:10.1128/mbio.01987-16 · Cited by 61
New aminoglycoside antibiotics
Dozzo, P., & Moser, H. E. (2010) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2010.506189 · Cited by 60
Leitzke, S., Bucke, W., Börner, K., Müller, R. H., Hahn, H. H., & Ehlers, S. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.2.459 · Cited by 59
Domain−Domain Interactions in the Aminoglycoside Antibiotic Resistance Enzyme AAC(6‘)-APH(2‘ ‘)
Boehr, D. D., Daigle, D. M., & Wright, G. D. (2004) · Biochemistry · doi:10.1021/bi049135y · Cited by 59
Making sense of antisense oligonucleotides: A narrative review
Goyal, N., & Narayanaswami, P. (2017) · Muscle & Nerve · doi:10.1002/mus.26001 · Cited by 56
Inhibition of Aminoglycoside Acetyltransferase Resistance Enzymes by Metal Salts
Li, Y., Green, K. D., Johnson, B. R., & Garneau‐Tsodikova, S. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00885-15 · Cited by 54
Du, Q., Dai, G., Long, Q., Yu, X., Dong, L., Huang, H., & Xie, J. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.06.031 · Cited by 54
A review of patents (2011–2015) towards combating resistance to and toxicity of aminoglycosides
Chandrika, N. T., & Garneau‐Tsodikova, S. (2015) · MedChemComm · doi:10.1039/c5md00453e · Cited by 54
Zhang, Y., Kashikar, A., & Bush, K. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx261 · Cited by 52
Mahmood, A., Karamat, K. A., & Butt, T. M. (2002) · PubMed · Cited by 51
Kirkwood, N. K., O’Reilly, M., Derudas, M., Kenyon, E. J., Huckvale, R., van Netten, S. M., Ward, S. E., Richardson, G. P., & Kros, C. J. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00262 · Cited by 49
Mechanism and evidence of nonsense suppression therapy for genetic eye disorders
Richardson, R., Smart, M. J. K., Tracey‐White, D., Webster, A. R., & Moosajee, M. (2017) · Experimental Eye Research · doi:10.1016/j.exer.2017.01.001 · Cited by 48
Tendon, V. D., Poirel, L., Connolly, L. E., Krause, K. M., & Nordmann, P. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx239 · Cited by 48
Management of Aminoglycosides in the Intensive Care Unit
Radigan, E., Gilchrist, N. A., & Miller, M. A. (2010) · Journal of Intensive Care Medicine · doi:10.1177/0885066610377968 · Cited by 47
Chiem, K., Fuentes, B. A., Lin, D. L., Tran, T., Jackson, A., Ramirez, M. S., & Tolmasky, M. E. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01106-15 · Cited by 45
Self-citationThe bifunctional enzymes of antibiotic resistance
Zhang, W., Fisher, J. F., & Mobashery, S. (2009) · Current Opinion in Microbiology · doi:10.1016/j.mib.2009.06.013 · Cited by 45
Jacoby, G. A. (1974) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.6.6.807 · Cited by 45
Lin, D. L., Tran, T., Alam, J. Y., Herron, S. R., Ramirez, M. S., & Tolmasky, M. E. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00129-14 · Cited by 44
Self-citationZimmermann, L., Das, I., Désiré, J., Sautrey, G., S., V. B. R., Khoury, M. E., Mingeot‐Leclercq, M., & Décout, J. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00818 · Cited by 44
Fosso, M. Y., Alfindee, M. N., Zhang, Q., Nziko, V. D. P. N., Kawasaki, Y., Shrestha, S. K., Bearss, J. J., Gregory, R., Takemoto, J. Y., & Chang, C. T. (2015) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.5b00248 · Cited by 42
Hassan, N., Awdallah, F. F., Abbassi, M., & Sabry, N. A. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002695 · Cited by 42
Malinin, V., Neville, M. E., Eagle, G. L., Gupta, R., & Perkins, W. R. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00700-16 · Cited by 41
Xiong, Y.-Q., Kupferwasser, L. I., Zack, P. M., & Bayer, A. S. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1737 · Cited by 39
Inhibition of gene expression by RNase P
Lundblad, E. W., & Altman, S. (2010) · New Biotechnology · doi:10.1016/j.nbt.2010.03.003 · Cited by 36
Hurwitz, C., Braun, C. B., & Rosano, C. L. (1981) · Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis · doi:10.1016/0005-2787(81)90220-3 · Cited by 36
Molecular Diversity and Plasmid Analysis of KPC-Producing Escherichia coli
Chavda, K. D., Chen, L., Jacobs, M. R., Bonomo, R. A., & Kreiswirth, B. N. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00452-16 · Cited by 36
Bacterial resistance to aminoglycosides and beta-lactams: the Tn1331 transposon paradigm
Marcelo, E. (1999) · Frontiers in bioscience · doi:10.2741/tolmasky · Cited by 35
Tada, T., Miyoshi‐Akiyama, T., Dahal, R. K., Mishra, S. K., Shimada, K., Ohara, H., Kirikae, T., & Pokhrel, B. M. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03354-14 · Cited by 35
Foster, C. R., & Champney, W. S. (2007) · Archives of Microbiology · doi:10.1007/s00203-007-0334-6 · Cited by 33
Díaz, M. C. L., Ríos, E., Rodríguez-Avial, I., Simaluiza, R. J., Picazo, J. J., & Culebras, E. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.01.039 · Cited by 33
External guide sequence technology: a path to development of novel antimicrobial therapeutics
Davies‐Sala, C., Soler‐Bistué, A., Bonomo, R. A., Zorreguieta, Á., & Tolmasky, M. E. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12755 · Cited by 31
Self-citationOptimizing the Initial Amikacin Dosage in Adults
White, B. P., Lomaestro, B. M., & Pai, M. P. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01032-15 · Cited by 30
Mechanisms of Resistance to Aminoglycoside Antibiotics
Umezawa, H., & Kondo, S. (1982) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-68579-8_6 · Cited by 29
Cleavage of RNA oligonucleotides by aminoglycosides
Belousoff, M. J., Graham, B., Spiccia, L., & Tor, Y. (2008) · Organic & Biomolecular Chemistry · doi:10.1039/b813252f · Cited by 29
Sadowy, E., Sieńko, A., Gawryszewska, I., Bojarska, A., Malinowska, K., & Hryniewicz, W. (2013) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-1868-y · Cited by 27
Lin, D. L., Tran, T., Adams, C., Alam, J. Y., Herron, S. R., & Tolmasky, M. E. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.08.016 · Cited by 26
Self-citationBurk, D. L., Xiong, B., Breitbach, C. J., & Berghuis, A. M. (2005) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444905021487 · Cited by 25
Understanding and overcoming aminoglycoside resistance caused by N-6′-acetyltransferase
Vong, K., & Auclair, K. (2011) · MedChemComm · doi:10.1039/c2md00253a · Cited by 25
Fair, R. J., McCoy, L. S., Hensler, M. E., Aguilar, B., Nizet, V., & Tor, Y. (2014) · ChemMedChem · doi:10.1002/cmdc.201402175 · Cited by 22
Tsimogianni, A. M., Alexandropoulos, P., Chantziara, V., Vassi, A., Micha, G., Lagiou, F., Chinou, E., Michaloudis, G., & Georgiou, S. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.01.002 · Cited by 21
Aminoglycoside-Modifying Enzymes: Characteristics, Localization, and Dissemination
Tolmasky, M. E. (2014) · ASM Press eBooks · doi:10.1128/9781555815615.ch4 · Cited by 19
Self-citationSmith, C. A., Tóth, M., Weiss, T. M., Frase, H., & Vakulenko, S. B. (2014) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s1399004714017635 · Cited by 19
Jackson, A., Jani, S., Davies‐Sala, C., Soler‐Bistué, A., Zorreguieta, Á., & Tolmasky, M. E. (2016) · Biology Methods and Protocols · doi:10.1093/biomethods/bpw001 · Cited by 19
Self-citationAminoglycosides: Mechanisms of Action and Resistance
Magalhães, M. D. L. B., & Blanchard, J. S. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-180-2_14 · Cited by 18
Kobayashi, K., Hayashi, I., Kouda, S., Kato, F., Fujiwara, T., Kayama, S., Hirakawa, H., Itaha, H., Ohge, H., Gotoh, N., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070557 · Cited by 16
mwr Xer site-specific recombination is hypersensitive to DNA supercoiling
Trigueros, S., Tran, T., Sorto, N. A., Newmark, J., Colloms, S. D., Sherratt, D. J., & Tolmasky, M. E. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp208 · Cited by 14
Self-citationSmith, C. A., Tóth, M., Bhattacharya, M., Frase, H., & Vakulenko, S. B. (2014) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s1399004714005331 · Cited by 13
Chow, V. C. Y., Hawkey, P. M., Chan, E. W., Chin, M. L., Au, T. K., Fung, D. K. C., & Chan, R. C. Y. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00603-06 · Cited by 13
Characterization of Tn 6238 with a New Allele of aac(6′)-Ib-cr
Quiroga, M. P., Orman, B. E., Errecalde, L., Kaufman, S. C., & Centrón, D. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03213-14 · Cited by 11
Insights into functional modulation of catalytic RNA activity
Vourekas, A., Stamatopoulou, V., Toumpeki, C., Tsitlaidou, M., & Drainas, D. (2008) · IUBMB Life · doi:10.1002/iub.105 · Cited by 9
(Non-)translational medicine: targeting bacterial RNA
Dinan, A. M., & Loftus, B. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00230 · Cited by 7
Tolmasky, M. E., Actis, L. A., & Crosa, J. H. (2010) · Encyclopedia of Industrial Biotechnology · doi:10.1002/9780470054581.eib487 · Cited by 5
Self-citation
Cited by
Mobile antimicrobial resistance genes in probiotics
Tóth, A. G., Csabai, I., Judge, M. F., Maróti, G., Becsei, Á., Spisák, S., & Solymosi, N. (2021) · doi:10.1101/2021.05.04.442546 · Cited by 97
Asafo-Adjei, K., Mensah, J. E., Labi, A.-K., Dayie, N. T. K. D., & Donkor, E. S. (2018) · Diseases · doi:10.3390/diseases6030065 · Cited by 24
Karikari, A. B., Saba, C. K., & Yamik, D. Y. (2022) · Microbiology Insights · doi:10.1177/11786361221106109 · Cited by 12
Metadata
- Authors
- Ramirez, M., & Tolmasky, M.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2017-12-19
- Volume
- 22
- Issue
- 12
- Pages
- 2267
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W2778440939
- Cited by
- 265
- References
- 141
- FWCI
- 5.09
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.